Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/21/2902514/0/en/Mustang-Bio-Announces-Closing-of-2-5-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/06/20/2901654/0/en/Mustang-Bio-Announces-2-5-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/06/17/2899667/0/en/Mustang-Bio-Announces-Favorable-Efficacy-and-Safety-Data-from-Complete-Waldenstrom-Macroglobulinemia-Cohort-of-Phase-1-2-Clinical-Trial-of-MB-106-CD20-Targeted-Autologous-CAR-T-The.html
https://www.globenewswire.com/news-release/2024/05/02/2874654/0/en/Mustang-Bio-Announces-Closing-of-4-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2024/04/30/2871745/0/en/Mustang-Bio-Announces-Pricing-of-4-Million-Public-Offering.html
https://endpts.com/mustang-bio-to-lay-off-workers-maats-new-data-for-microbiome-therapy/
https://www.globenewswire.com/news-release/2024/03/28/2854074/0/en/Mustang-Bio-Announces-Vision-for-CAR-T-Cell-Therapy-Platform-Expansion-into-Autoimmune-Diseases.html
https://www.fiercebiotech.com/research/mustang-bio-and-city-hope-car-t-therapy-glioblastoma-extends-survival-phase-1-trial
https://www.globenewswire.com//news-release/2024/03/11/2844140/0/en/Mustang-Bio-Reports-Full-Year-2023-Financial-Results-and-Recent-Corporate-Highlights.html
https://www.globenewswire.com//news-release/2024/03/07/2842161/0/en/Mustang-Bio-Announces-Publication-in-Nature-Medicine-of-Data-from-Phase-1-Trial-Evaluating-MB-101-IL13R%CE%B12-targeted-CAR-T-Cells-in-High-Grade-Glioma.html